Wealth Enhancement Advisory Services’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.7K | Buy |
37,128
+1,512
| +4% | +$3.33K | ﹤0.01% | 3145 |
|
|
2025
Q1 | $78.4K | Buy |
35,616
+482
| +1% | +$1.06K | ﹤0.01% | 2778 |
|
|
2024
Q4 | $53.8K | Sell |
35,134
-10,139
| -22% | -$15.5K | ﹤0.01% | 2823 |
|
|
2024
Q3 | $90.1K | Buy |
45,273
+7,927
| +21% | +$15.8K | ﹤0.01% | 2539 |
|
|
2024
Q2 | $131K | Buy |
37,346
+1,366
| +4% | +$4.78K | ﹤0.01% | 2359 |
|
|
2024
Q1 | $99.7K | Buy |
35,980
+9
| +0% | +$25 | ﹤0.01% | 2290 |
|
|
2023
Q4 | $61.2K | Sell |
35,971
-1,640
| -4% | -$2.79K | ﹤0.01% | 2197 |
|
|
2023
Q3 | $38.7K | Buy |
+37,611
| New | +$38.7K | ﹤0.01% | 2142 |
|